Contact Us: 01282 426380
KM Financial Solutions | Novartis sickle-cell drug gets U.S. FDA approval
55708
post-template-default,single,single-post,postid-55708,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Novartis sickle-cell drug gets U.S. FDA approval

14 Nov Novartis sickle-cell drug gets U.S. FDA approval

Posted at 20:07h in News by
0 Likes
Novartis on Friday won U.S.
approval for its experimental sickle cell disease drug, making
it the first of several proposed new therapies designed to offer
lasting relief for patients with the debilitating blood disease
to get U.S. regulatory clearance.

No Comments

Sorry, the comment form is closed at this time.